Hans Moebius, Chief Medical Officer at Athira Pharma, Inc. (ATHA), bought 10,000 shares at $2.88 ($29K) on 2022-06-28, disclosed to the SEC on 2022-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.